NOSIUM B Stock Overview
Nosium AB (publ) develops, distributes, and sells natural beauty and health products in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Nosium AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.012 |
| 52 Week High | kr0 |
| 52 Week Low | kr0 |
| Beta | 0.43 |
| 1 Month Change | -45.45% |
| 3 Month Change | -90.70% |
| 1 Year Change | -98.05% |
| 3 Year Change | -99.00% |
| 5 Year Change | -97.00% |
| Change since IPO | -99.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| NOSIUM B | SE Personal Products | SE Market | |
|---|---|---|---|
| 7D | -14.3% | 1.5% | -0.7% |
| 1Y | -98.0% | 13.2% | 4.4% |
Return vs Industry: NOSIUM B underperformed the Swedish Personal Products industry which returned 14.1% over the past year.
Return vs Market: NOSIUM B underperformed the Swedish Market which returned 10.3% over the past year.
Price Volatility
| NOSIUM B volatility | |
|---|---|
| NOSIUM B Average Weekly Movement | 45.9% |
| Personal Products Industry Average Movement | 4.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 13.1% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: NOSIUM B's share price has been volatile over the past 3 months.
Volatility Over Time: NOSIUM B's weekly volatility has increased from 26% to 46% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 12 | Daniel Ehdin | nosium.com |
Nosium AB (publ) develops, distributes, and sells natural beauty and health products in Sweden. The company was formerly known as Scandinavian Health Innovations AB (publ) and changed its name to Nosium AB (publ) in June 2021. Nosium AB (publ) was founded in 1994 and is headquartered in Stockholm, Sweden.
Nosium AB (publ) Fundamentals Summary
| NOSIUM B fundamental statistics | |
|---|---|
| Market cap | kr969.56k |
| Earnings (TTM) | -kr22.44m |
| Revenue (TTM) | kr18.78m |
0.0x
P/S Ratio0.0x
P/E RatioIs NOSIUM B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NOSIUM B income statement (TTM) | |
|---|---|
| Revenue | kr18.78m |
| Cost of Revenue | kr8.80m |
| Gross Profit | kr9.98m |
| Other Expenses | kr32.42m |
| Earnings | -kr22.44m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.32 |
| Gross Margin | 53.12% |
| Net Profit Margin | -119.52% |
| Debt/Equity Ratio | 15.6% |
How did NOSIUM B perform over the long term?
See historical performance and comparison